Caco-2 cells were maintained in DMEM supplemented with 10% fetal bovine serum and 1% Pen/Strep. For the establishment of CTX resistant Caco-2 clones (Caco-2 CXR) please refer to our previous work [21 (link)]. Caco-2 CXR were maintained in presence of cetuximab (Erbitux, Merck KgaA, Germany) at 10 µg/mL concentration. Caco-2 cells were authenticated by short tandem repeat (STR) profiling (PowerPlex 21 PCR Kit, Promega, Madison, WI, USA) and the certificate was released by the external service Eurofins Medigenomix Forensik GmbH (Ebersberg, Germany). Cells were routinely tested for mycoplasma contamination.
Free full text: Click here